-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
LIPELLA PHARMACEUTICALS INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2021 to Q3 2025.
- LIPELLA PHARMACEUTICALS INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 4,549,120, a 306% increase year-over-year.
- LIPELLA PHARMACEUTICALS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1,048,185, a 40% increase from 2023.
- LIPELLA PHARMACEUTICALS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 750,383, a 82% decline from 2022.
- LIPELLA PHARMACEUTICALS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4,060,624, a 19% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)